Spectra for:
Bhupendrasinh Vaghela
Compound A N-OXIDE-IMPURITY;2-[4-[1-HYDROXY-4-[4-[HYDROXY-(DIPHENYL)-METHYL]-1-OXIDOPIPERIDIN-1-YL]-BUTYL]-PHENYL]-2-METHYL-PROPANOIC-ACID
![N-OXIDE-IMPURITY;2-[4-[1-HYDROXY-4-[4-[HYDROXY-(DIPHENYL)-METHYL]-1-OXIDOPIPERIDIN-1-YL]-BUTYL]-PHENYL]-2-METHYL-PROPANOIC-ACID](/api/compound/1MfbUTHWagA.png?h=300&w=458 "N-OXIDE-IMPURITY;2-[4-[1-HYDROXY-4-[4-[HYDROXY-(DIPHENYL)-METHYL]-1-OXIDOPIPERIDIN-1-YL]-BUTYL]-PHENYL]-2-METHYL-PROPANOIC-ACID")
Compound B Fexofenadine breakdown (439)
Citation
| Citation | SCI.PHARM.,80,295(2012) |
|---|---|
| Journal | Scientia Pharmaceutica |
| Issue | 2 |
| Volume | 80 |
| Page(s) | 295-309 |
| Year | 2012 |
| Author(s) | Bhupendrasinh Vaghela |
| Publisher | MDPI AG |
| DOI | 10.3797/scipharm.1111-07 |